CHEMED CORP (CHE) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-05-08

Key Insights

Director Patrick P. Grace sold 60 shares of CHE at $425.78 per share on 05/08/2026, generating approximately $25,547 in proceeds, indicating a modest insider sale rather than a significant position reduction.
Grace's remaining beneficial ownership of 3,337 shares suggests he maintains a meaningful stake in the company despite the sale, with no apparent loss of confidence in Chemed's prospects.
The sale appears to be a routine transaction for a director-level executive, with no indication of distress selling or large-scale insider liquidation that would raise red flags for investors.

Want the newest filings?

This analysis covers the filing from 2026-05-08. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-05-04

CEO Kevin McNamara sold 2,000 shares of CHE on May 1, 2026 at a weighted average price of $421.13, with prices ranging from $418.99 to $424.95, reducing his direct beneficial ownership to 90,219 shares.
This represents a relatively modest insider sale of approximately 2.2% of the reported beneficial ownership, suggesting measured portfolio rebalancing rather than a significant loss of confidence in the company.
The sale occurred at a time when the stock was trading near $421, indicating the executive executed the transaction at market prices without any apparent urgency or distressed selling patterns.

Filed: 2026-03-30

Kevin J. McNamara, the President and CEO of Chemed Corp, has sold 1,500 shares of the company's capital stock at an average price of $369.37.
Following this transaction, McNamara still holds a direct ownership of 92,219 shares in the company.
The filing indicates that the sale was conducted pursuant to a Rule 10b5-1 trading plan, which suggests a pre-planned transaction.

Filed: 2026-02-17

Insider Brian C. Judkins, Vice President and Chief Legal Officer, exercised 351 performance stock units (PSUs) and sold 102 shares to cover tax obligations, indicating continued ownership and confidence in the company.
The company met or exceeded performance targets for the 2023-2025 period, with the CEO receiving 124.1% of target PSUs, while the relative TSR target was not met, resulting in a 0% payout.
The company granted an additional 908 PSUs to the insider, which will vest based on 2026-2028 performance targets, aligning executive compensation with long-term shareholder value creation.

Filed: 2026-02-17

Kevin J. McNamara, the president and CEO of Chemed Corp, exercised 4,901 performance stock units (PSUs) on February 13, 2026, with 2,714 shares acquired and 1,192 shares withheld for tax purposes.
The PSUs that vested were based on the company's cumulative adjusted earnings per share and relative total shareholder return performance over the 2023-2025 period, with the earnings-based PSUs exceeding the maximum payout threshold.
McNamara was also awarded an additional 5,114 PSUs that will vest based on the company's performance over the 2026-2028 period, indicating continued confidence in the company's long-term outlook.

Filed: 2026-02-17

Michael D. Witzeman, the VP & Chief Financial Officer of Chemed Corp, exercised 413 performance stock units (PSUs) and acquired 333 additional PSUs, indicating insider activity and confidence in the company's long-term performance.
The vested PSUs were settled in Chemed Corp's capital stock, but Witzeman also disposed of 120 shares to satisfy tax obligations, suggesting a balance between holding and liquidating shares.
The new PSU grant with a 3-year performance period from 2026-2028 suggests Chemed Corp's management is incentivized to drive long-term shareholder value through its strategic initiatives.

Filed: 2026-02-17

CEO Joel L. Wherley exercised 273 performance stock units (PSUs) and sold 80 shares to cover tax obligations, indicating a shift in his equity stake in the company.
The vesting of the PSUs was based on the company's strong financial performance, with cumulative adjusted earnings per share exceeding the maximum payout threshold.
The company also granted an additional 1,142 PSUs to Wherley, which will vest based on future performance targets over the next 3 years.

Filed: 2026-02-17

Thomas C. Hutton, a vice president at Chemed Corp (CHE), exercised 359 performance stock units and received 160 shares of company stock.
Hutton sold 72 shares to cover tax obligations, reducing his direct beneficial ownership to 32,481 shares.
The company awarded Hutton an additional 374 performance stock units, further aligning his interests with shareholders.

Filed: 2026-02-17

The reporting person, Spencer S. Lee, is the executive vice president of Chemed Corp (CHE) and has made several transactions related to performance stock units (PSUs).
Lee has exercised 499 PSUs and sold 154 shares to cover tax obligations, indicating some insider selling activity.
The company has granted an additional 960 PSUs to Lee, which will vest based on future performance targets over the next 3 years.

Filed: 2025-12-29

Insider Andrea R. Lindell has disposed of 463 shares of Chemed Corporation (CHE) stock, reducing her direct ownership to 5,539 shares.
The transaction was executed on December 26, 2025, with no additional details provided on the purpose or circumstances of the sale.
Insider transactions can provide insights into management's views on the company's prospects, so this sale may warrant further investigation by investors.

Other reports for CHEMED CORP

Quarterly Report Current Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.